Seneste diskussioner
Why is there a wide analyst price target range ($1.01 to $6.30) for GERN as of August 6, 2025?
What recent unusual options flow or implied volatility changes indicate market expectations for GERN?
What are the latest updates on RYTELO's commercial launch, market penetration, and prescriber adoption since June 2024?
What factors motivated Deep Track Capital's 362.04% increase in GERN shares during Q1 2025?
What are the potential liabilities from the consolidated securities class action lawsuits filed in March 2025?
How has Fintel's Insider Sentiment score for GERN changed since Harout Semerjian's CEO appointment on August 6, 2025?
How will the Q2 2025 inventory increase to $69.1 million impact future cost of goods sold?
what is projected NPV of Geron stock price using Revenue and P/S thru 2033
How might evolving healthcare policy or interest rates impact GERN's long-term growth strategy?
What drove the 67.75% decline in GERN's share price between September 6, 2024, and September 5, 2025, despite institutional ownership stability?
EU Launch AI+
is it better for Geron to launch rytelo alone or with a partner in the EU
How will the planned 2026 EU commercial launch of RYTELO impact GERN's revenue growth trajectory? AI+
How will the planned 2026 EU commercial launch of RYTELO impact GERN's revenue growth trajectory?
What are the commercialization strategies for RYTELO in the EU, with launch expected in 2026?
Why did Deep Track Capital increase its GERN stake by 362% in March 2025, while RTW Investments exited?
What market penetration has Rytelo achieved since its June 2024 FDA approval?
What is the market sentiment indicated by the recent surge in call option volume for GERN, particularly for expirations in late 2025?
Why did Scotiabank downgrade Geron to 'Sector Perform' on May 8th, and how does this align with current analyst price targets?
How has the significant year-over-year price decline of ~70% impacted institutional sentiment and fund allocation changes for GERN?
